Cargando…

COVID-19 and treating incarcerated populations for opioid use disorder

The Franklin County Sheriff's Office (FCSO), in Greenfield, Massachusetts, is among the first jails nationwide to provide correctional populations with access to all three medications to treat opioid use disorder (MOUD, i.e., buprenorphine, methadone, naltrexone). In response to the COVID-19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donelan, Christopher J., Hayes, Edmond, Potee, Ruth A., Schwartz, Levin, Evans, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708799/ https://www.ncbi.nlm.nih.gov/pubmed/33288348 http://dx.doi.org/10.1016/j.jsat.2020.108216

Ejemplares similares

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
por: Chatterjee, Avik, et al.
Publicado: (2023)

The perfect storm: COVID-19, mass incarceration and the opioid epidemic
por: Mukherjee, Trena I., et al.
Publicado: (2020)

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder
por: Chappuy, Mathieu, et al.
Publicado: (2021)

Medications for opioid use disorder during incarceration and post-release outcomes
por: Cates, Lara, et al.
Publicado: (2023)

The impact of COVID-19 on opioid toxicity deaths for people who experience incarceration compared to the general population in Ontario: A whole population data linkage study
por: Butler, Amanda, et al.
Publicado: (2023)

Prioritizing incarcerated populations for COVID-19 vaccination and vaccine trials
por: Kronfli, Nadine, et al.
Publicado: (2020)

COVID-19: The Additional Sentence for the Incarcerated
por: Otugo, Onyeka, et al.
Publicado: (2020)

Care for Incarcerated Patients Hospitalized with COVID-19
por: Jacobsen, Alan P., et al.
Publicado: (2021)

Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration
por: Palis, Heather, et al.
Publicado: (2022)

Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration
por: Cadet, Techna, et al.
Publicado: (2023)

Identifying and Treating Incarcerated Women Experiencing Substance Use Disorders: A Review
por: Staton, Michele, et al.
Publicado: (2023)

Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder
por: Fox, Aaron D, et al.
Publicado: (2015)

Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder
por: Belcher, Annabelle M., et al.
Publicado: (2021)

Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health
por: Sugarman, Olivia K., et al.
Publicado: (2020)

COVID-19 in corrections: Quarantine of incarcerated people
por: Maner, Morgan, et al.
Publicado: (2021)

COVID-19 and pregnancy care for incarcerated women
por: Hutchinson-Colas, Juana, et al.
Publicado: (2021)

Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
por: Nunes, Edward V., et al.
Publicado: (2021)

Epidemic Meets Pandemic:: Treating Opioid Use Disorder in the Age of COVID-19
por: Williams, Kimberly D., et al.
Publicado: (2020)

Co-morbid psychiatric disorders among incarcerated ADHD populations: a meta-analysis
por: Young, S., et al.
Publicado: (2015)

Prevalence Rates and Evolution of Psychiatric Disorders Among Incarcerated Youths in Comparison With Non-incarcerated Youths
por: Heller, Patrick, et al.
Publicado: (2022)

Carceral Amplification of COVID-19: Impacts for Community, Corrections Officer, and Incarcerated Population Risks
por: Lofgren, Eric T., et al.
Publicado: (2022)

COVID-19 vaccine deliberation in individuals directly impacted by incarceration
por: Kim, Charlotte, et al.
Publicado: (2023)

Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada
por: Park, Hyejin, et al.
Publicado: (2022)

A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations
por: Young, S., et al.
Publicado: (2015)

Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review
por: Malta, Monica, et al.
Publicado: (2019)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
por: Russell, Cayley, et al.
Publicado: (2022)

Substance use disorders in prisoners: an updated systematic review and meta‐regression analysis in recently incarcerated men and women
por: Fazel, Seena, et al.
Publicado: (2017)

Ethical inclusion: Risks and benefits of research from the perspective of perinatal people with opioid use disorders who have experienced incarceration
por: Reddy, Julia, et al.
Publicado: (2023)

COVID-19's Effect on Pregnancy Care for Incarcerated People
por: Kramer, Camille, et al.
Publicado: (2022)

FORMER INCARCERATION AS A RISK FACTOR FOR COVID-19 ASSOCIATED SUDDEN DEATH
por: Raghunathan, Sahana, et al.
Publicado: (2022)

Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015–2020: a whole population retrospective cohort study
por: Butler, Amanda, et al.
Publicado: (2023)

Diagnosis of Biceps Incarceration: Observations on the Biceps Incarceration Maneuver
por: Knapik, Derrick M., et al.
Publicado: (2021)

COVID-19 and mass incarceration: a call for urgent action
por: Macmadu, Alexandria, et al.
Publicado: (2020)

The solitary confinement of incarcerated American youth during COVID-19
por: Gagnon, Joseph Calvin
Publicado: (2020)

The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study
por: Saunders, Elizabeth C., et al.
Publicado: (2022)

Hospitalizations for COVID-19 Among US People Experiencing Incarceration or Homelessness
por: Montgomery, Martha P., et al.
Publicado: (2022)

Laser lithotripsy to treat a huge incarcerated esophageal bezoar
por: Song, Ruifeng, et al.
Publicado: (2022)

Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
por: Lind, Margaret L., et al.
Publicado: (2023)

Incarceration status and cancer mortality: A population-based study
por: Oladeru, Oluwadamilola T., et al.
Publicado: (2022)

Dying Without COVID-19: End-of-Life Care for an Uninfected Incarcerated Patient
por: Jacobsen, Alan P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nrj2rapc1llue2airr2knvdveo